Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

iShares STOXX Europe 600 Health Care UCITS (SXDPEX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
113.30 -0.54    -0.47%
03/05 - Closed. Currency in EUR ( Disclaimer )
  • Volume: 30,596
  • Bid/Ask: 113.28 / 113.40
  • Day's Range: 112.78 - 113.82
Type:  ETF
Market:  Germany
Issuer:  iShares
ISIN:  DE000A0Q4R36 
WKN:  A0Q4R3
Underlying:  STXE Health Care NR
Asset Class:  Equity
iShares STOXX Europe 600 Health Care UCITS 113.30 -0.54 -0.47%

SXDPEX Recent Sentiments

 
Information on users’ sentiments for the iShares STOXX Europe 600 Health Care UCITS ETF, which are displayed both on charts of different periods of time and on a detailed table.
Start Date Username Call Open Rate End Date Chg. %
Feb 08, 2023 Artur Chudy   102.06 Feb 13, 2023 @ 101.66 -0.39%
Feb 01, 2022 Artur Chudy   101.30 Feb 25, 2022 @ 100.02 -1.26%
Jan 03, 2022 Luis Martin Albarran   108.48 Jan 28, 2022 @ 100.34 -7.50%
Nov 30, 2021 Paulo Morais   101.84 Dec 24, 2021 @ 106.34 +4.42%
Nov 16, 2021 Luis Martin Albarran   106.00 Dec 10, 2021 @ 104.38 -1.53%
Nov 04, 2021 Kim Andreasen   108.30 Nov 26, 2021 @ 102.62 -5.24%
Sep 23, 2021 Phil FF   101.88 Oct 15, 2021 @ 101.20 -0.67%
Sep 17, 2021 jay irani   100.00 Sep 20, 2021 @ 100.28 +0.28%
Aug 27, 2021 Paweł Rytel   104.16 Sep 17, 2021 @ 100.04 -3.96%
Jan 05, 2021 Giorgos Emmanouilidis   88.16 Jan 29, 2021 @ 87.55 -0.69%
Nov 24, 2020 Joe Maspo   86.57 Dec 18, 2020 @ 87.38 +0.94%
Oct 21, 2020 Yoel Peyser   86.55 Nov 13, 2020 @ 89.51 -3.42%
Sep 04, 2020 viacheslav chernyshev   87.97 Sep 25, 2020 @ 89.48 -1.72%
Aug 31, 2020 Emanuele Te   87.88 Sep 25, 2020 @ 89.48 +1.82%
Aug 04, 2020 Savvas Stampolloglou   89.72 Aug 28, 2020 @ 88.23 +1.66%
Jun 09, 2020 Tomasz Szuba   92.13 Jun 09, 2020 @ 92.13 0.00%
May 12, 2020 Wolfgang Tillmann   93.28 Jun 05, 2020 @ 91.92 -1.46%
Apr 28, 2020 Martijn Bakker   92.65 May 22, 2020 @ 92.92 -0.29%
Apr 16, 2020 Constantin Hermann   87.54 May 08, 2020 @ 92.08 +5.19%
Apr 06, 2020 Eugenio Barbarini   85.25 May 01, 2020 @ 90.61 +6.29%
Mar 30, 2020 David Kotthoff   80.57 Apr 24, 2020 @ 91.43 +13.48%
Mar 30, 2020 Egon Debel   79.70 Apr 24, 2020 @ 91.43 +14.72%
Feb 20, 2020 Koen Van Eycken   97.00 Feb 27, 2020 @ 89.11 -8.13%
Jan 24, 2020 Diogo Cruz   93.97 Feb 14, 2020 @ 95.70 +1.84%
Nov 27, 2019 Karim Hassan   88.90 Dec 20, 2019 @ 90.96 +2.32%
Sep 24, 2019 Peter Haberbosch   84.36 Oct 18, 2019 @ 82.74 -1.92%
Dec 14, 2018 Paulo Cerquinho   72.59 Jan 13, 2019 @ 79.11 +8.98%
Oct 29, 2018 Nikolaos Englezopoulo   71.05 Nov 28, 2018 @ 79.11 +11.34%
Oct 22, 2018 ROMAN MIGUEL   73.55 Nov 21, 2018 @ 79.11 +7.56%
Jul 10, 2018 Nikolaos Englezopoulo   74.06 Aug 09, 2018 @ 76.51 +3.31%
Apr 04, 2018 Hermann Albrecht   67.82 Apr 11, 2018 @ 69.99 +3.20%
Mar 27, 2018 Nikolaos Englezopoulo   67.30 Apr 26, 2018 @ 69.29 +2.96%
Feb 18, 2018 Nikolaos Englezopoulo   68.95 Mar 20, 2018 @ 68.40 -0.80%
Sep 01, 2015 Michał Pustelnik   76.68 Oct 01, 2015 @ 75.52 +1.51%
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

SXDPEX Comments

Write your thoughts about iShares STOXX Europe 600 Health Care UCITS
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email